Endometrial cancer screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Endometrial cancer}} | {{Endometrial cancer}} | ||
{{CMG}}{{AE}}{{MD}} | {{CMG}}{{AE}}{{MD}}{{RAK}} | ||
==Overview== | ==Overview== | ||
| Line 8: | Line 8: | ||
There is insufficient evidence to recommend routine screening for endometrial cancer.<ref name="endometrialcancerscreening">{{Cite web | title =Endometrial Cancer Screening| url = http://www.cancer.gov/types/uterine/patient/endometrial-screening-pdq#section/_13}}</ref> | There is insufficient evidence to recommend routine screening for endometrial cancer.<ref name="endometrialcancerscreening">{{Cite web | title =Endometrial Cancer Screening| url = http://www.cancer.gov/types/uterine/patient/endometrial-screening-pdq#section/_13}}</ref> | ||
Women with Lynch syndrome have a risk of developing endometrial cancer up to 50% higher than the general population. | Women with [[Lynch|Lynch syndrome]] have a risk of developing endometrial cancer up to 50% higher than the general population. | ||
* Screening for endometrial cancer in women with Lynch syndrome by annual endometrial sampling is recommended starting at age 30 to 35 (or 5 to 10 years prior to the first diagnosed Lynch syndrome-associated cancer in a family member).<ref name="pmid17003399">{{cite journal| author=Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH et al.| title=Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. | journal=JAMA | year= 2006 | volume= 296 | issue= 12 | pages= 1507-17 | pmid=17003399 | doi=10.1001/jama.296.12.1507 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17003399 }} </ref> | * Screening for endometrial cancer in women with Lynch syndrome by annual endometrial sampling is recommended starting at age 30 to 35 (or 5 to 10 years prior to the first diagnosed Lynch syndrome-associated cancer in a family member).<ref name="pmid17003399">{{cite journal| author=Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH et al.| title=Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. | journal=JAMA | year= 2006 | volume= 296 | issue= 12 | pages= 1507-17 | pmid=17003399 | doi=10.1001/jama.296.12.1507 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17003399 }} </ref> | ||
Latest revision as of 14:08, 29 November 2018
|
Endometrial cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Endometrial cancer screening On the Web |
|
American Roentgen Ray Society Images of Endometrial cancer screening |
|
Risk calculators and risk factors for Endometrial cancer screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]Roukoz A. Karam, M.D.[3]
Overview
There is insufficient evidence to recommend routine screening for endometrial cancer.[1]
Endometrial Cancer Screening
There is insufficient evidence to recommend routine screening for endometrial cancer.[1]
Women with Lynch syndrome have a risk of developing endometrial cancer up to 50% higher than the general population.
- Screening for endometrial cancer in women with Lynch syndrome by annual endometrial sampling is recommended starting at age 30 to 35 (or 5 to 10 years prior to the first diagnosed Lynch syndrome-associated cancer in a family member).[2]
References
- ↑ 1.0 1.1 "Endometrial Cancer Screening".
- ↑ Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH; et al. (2006). "Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review". JAMA. 296 (12): 1507–17. doi:10.1001/jama.296.12.1507. PMID 17003399.